Outcomes Following Pre-marking of Episiotomy Location
Launched by SHARON DAVIDESKO MD · Jan 20, 2021
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes for women who have an episiotomy—a procedure where a small cut is made in the vaginal area during childbirth. The goal is to see if marking the location for the cut during the early stages of labor improves results compared to when the cut is made without any marking. Researchers want to find out whether this marking helps reduce complications, such as extended tears or infections, both right after delivery and in the long term.
To participate in this study, women must be at least 18 years old and in active labor at the hospital where the trial is taking place. If you choose to join, you'll be part of a process that compares your experience with others who have not had the marking done. This research aims to understand better ways to support women during childbirth and improve their recovery afterward. If you are eligible and decide to participate, you will be helping to gather important information that could benefit future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women 18 years of age or older who present in active labour to our center and consent to participate in the study
- Exclusion Criteria:
- • women under 18 years of age or those who do not or are unable to provide informed consent to participate in the study
About Sharon Davidesko Md
Dr. Sharon Davidesko, MD, is a distinguished clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical practice and a focus on innovative therapeutic approaches, Dr. Davidesko leads trials that rigorously evaluate new treatments across various medical conditions. Her dedication to ethical standards and patient safety ensures that all studies are conducted with the utmost integrity, fostering collaboration among multidisciplinary teams to drive scientific discovery and enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Be'er Sheva, , Israel
Be'er Sheva, , Israel
Patients applied
Trial Officials
Sharon Davidesko, MD
Principal Investigator
Soroka University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials